Compare ICICI Prudential Nifty Pharma Index Fund vs Tata India Pharma & Healthcare Fund
Risk
Very High
Very High
Rating
2.0
3.0
Min SIP Amount
₹1000
₹100
Expense Ratio
1.05
2.15
NAV
₹16.52
₹27.91
Fund Started
25 Nov 2022
04 Dec 2015
Fund Size
₹97.03 Cr
₹1300.81 Cr
Exit Load
-
Exit load of 0.25% if redeemed within 30 days.
1 Year
3.70%
-2.03%
3 Year
20.94%
20.63%
5 Year
-
13.50%
Equity
99.35%
97.56%
Cash
0.65%
2.44%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 21.81% |
Divi's Laboratories Ltd. | 9.65% |
Dr. Reddy's Laboratories Ltd. | 9.29% |
Cipla Ltd. | 8.99% |
Lupin Ltd. | 6.62% |
Torrent Pharmaceuticals Ltd. | 5.37% |
Laurus Labs Ltd. | 4.96% |
Aurobindo Pharma Ltd. | 4.05% |
Alkem Laboratories Ltd. | 3.91% |
Glenmark Pharmaceuticals Ltd. | 3.81% |
Sun Pharmaceutical Industries Ltd. | 9.66% |
Max Healthcare Institute Ltd. | 6.78% |
Divi's Laboratories Ltd. | 5.94% |
Abbott India Ltd. | 5.60% |
Healthcare Global Enterprises Ltd. | 5.04% |
Apollo Hospitals Enterprise Ltd. | 5.00% |
Cipla Ltd. | 4.55% |
Rainbow Children's Medicare Ltd. | 3.83% |
Mankind Pharma Ltd. | 3.40% |
Bayer CropScience Ltd. | 3.33% |
Name
-
-
Start Date
-
-
Description
The Scheme seeks to invest in companies whose securities are included in Nifty Pharma Index and subject to tracking errors, to endeavor to achieve the returns of the above index. This would be done by investing in all the stocks comprising the Nifty Pharma Index in the same weightage that they represent in Nifty Pharma Index
The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.
Launch Date
25 Nov 2022
04 Dec 2015
